Update out today for new entity, Qbiotics Group. Some key points:
- Veterinary side of things is going well with success rate having improved!
- Human data is being collated but initial examination of the safety and efficacy are 'very encouraging'
- Results from initial preclinical research into the effect on metastatic cancers of combining tigilanol tiglate with immune checkpoint inhibitors has proven encouraging. (THIS COULD BE HUUUGE)
- They've bought a property in the Atherton Tablelands to grow Fontainea.
